Manish Hathiramani of Deen Dayal Investments advises buying Dr Reddys Laboratories.
Manish Hathiramani of Deen Dayal Investments told CNBC-TV18, "Pharma seems to have broken out with this slight correction and then after that is an up move on the Nifty. The buy on Dr Reddys Laboratories from my side is with a target of Rs 3,800 and stop loss of Rs 3,470."
He further added, "This stock again has taken very good support in the recent correction and has gone past the resistance levels of Rs 3,475. We have even very good volumes. So, I would even recommend an accumulation on dips for those who are in the investment fraternity."
Disclosure: Analyst has no personal positions in the above stock but in Adani Enterprises family and relatives have the positions.